Drug Shortage Report for LACTULOSE SOLUTION USP
Report ID | 38529 |
Drug Identification Number | 02242814 |
Brand name | APO-LACTULOSE |
Common or Proper name | LACTULOSE |
Company Name | BAJAJ MEDICAL, LLC |
Market Status | DORMANT |
Active Ingredient(s) | LACTULOSE |
Strength(s) | 667MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL |
Packaging size | 500 ML |
ATC code | A06AD |
ATC description | DRUGS FOR CONSTIPATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-05-04 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2018-07-12 |
Shortage status | Resolved |
Updated date | 2018-07-17 |
Company comments | no production planned for the foreseeable future |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 415 W PERSHING RD CHICAGO, ILLINOIS UNITED STATES 60609 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-07-17 | French | Compare |
v4 | 2018-07-17 | English | Compare |
v3 | 2018-05-05 | English | Compare |
v2 | 2018-02-05 | French | Compare |
v1 | 2018-02-05 | English | Compare |
Showing 1 to 5 of 5